AAPL330.15-2.93 (-0.88%) ▼|ABBV261.82+0.05 (+0.02%) ▲|ABT102.05-1.04 (-1.01%) ▼|ACN194.66-0.34 (-0.17%) ▼|ADBE260.05-5.55 (-2.09%) ▼|AMAT420.34-3.87 (-0.91%) ▼|AMD503.64+10.23 (+2.07%) ▲|AMGN375.43-6.07 (-1.59%) ▼|AMT177.75+0.81 (+0.46%) ▲|AMZN248.04-5.50 (-2.17%) ▼|AVGO339.59-5.14 (-1.49%) ▼|AXP324.24-3.54 (-1.08%) ▼|BA209.32-0.96 (-0.45%) ▼|BAC59.57+0.10 (+0.16%) ▲|BKNG171.75-3.60 (-2.05%) ▼|BLK1,058.41-7.19 (-0.67%) ▼|BMY63.75-0.36 (-0.55%) ▼|BNY155.31-2.36 (-1.49%) ▼|BRK-B515.35+0.40 (+0.08%) ▲|C136.06-0.12 (-0.09%) ▼|CAT782.00-2.01 (-0.26%) ▼|CL87.11-0.78 (-0.89%) ▼|CMCSA24.54-0.35 (-1.39%) ▼|COF206.82+0.14 (+0.07%) ▲|COP140.51+3.84 (+2.81%) ▲|COST902.45-16.46 (-1.79%) ▼|CRM255.60-3.83 (-1.48%) ▼|CSCO110.05-0.01 (-0.01%) ▼|CVS94.67-0.88 (-0.92%) ▼|CVX216.81+4.64 (+2.18%) ▲|DE682.14+0.68 (+0.10%) ▲|DHR208.76+5.51 (+2.71%) ▲|DIS106.22-2.38 (-2.19%) ▼|DUK118.22-0.80 (-0.67%) ▼|EMR146.88-1.42 (-0.96%) ▼|FDX309.40-3.17 (-1.01%) ▼|GD359.64+2.83 (+0.79%) ▲|GE308.21-9.35 (-2.94%) ▼|GEV880.60+5.84 (+0.67%) ▲|GILD145.79+0.20 (+0.13%) ▲|GM85.32-1.84 (-2.11%) ▼|GOOG340.28-5.43 (-1.57%) ▼|GOOGL343.77-5.62 (-1.61%) ▼|GS974.89-13.57 (-1.37%) ▼|HD305.45-5.42 (-1.74%) ▼|HON204.74+3.36 (+1.67%) ▲|IBM248.04-1.06 (-0.42%) ▼|INTC97.14-0.05 (-0.05%) ▼|INTU331.51-7.64 (-2.25%) ▼|ISRG377.03-0.91 (-0.24%) ▼|JNJ266.35+0.03 (+0.01%) ▲|JPM353.60+3.47 (+0.99%) ▲|KO88.64-0.18 (-0.20%) ▼|LIN461.69-2.72 (-0.59%) ▼|LLY1,134.06-4.22 (-0.37%) ▼|LMT534.32+4.94 (+0.93%) ▲|LOW195.04-3.14 (-1.58%) ▼|LRCX269.51-3.98 (-1.46%) ▼|MA571.68-2.74 (-0.48%) ▼|MCD253.54-3.96 (-1.54%) ▼|MDLZ62.20-0.19 (-0.30%) ▼|MDT93.74-0.06 (-0.06%) ▼|META668.91+3.31 (+0.50%) ▲|MMM165.08+3.06 (+1.89%) ▲|MO70.11+0.61 (+0.88%) ▲|MRK143.87-0.13 (-0.09%) ▼|MS205.86-0.73 (-0.35%) ▼|MSFT496.00-9.41 (-1.86%) ▼|MU924.38+0.35 (+0.04%) ▲|NEE81.28-0.35 (-0.43%) ▼|NFLX77.96-2.37 (-2.94%) ▼|NKE36.26-0.80 (-2.15%) ▼|NOW142.54+0.19 (+0.13%) ▲|NVDA211.90+0.94 (+0.44%) ▲|ORCL140.19-4.61 (-3.18%) ▼|PEP135.64-0.70 (-0.51%) ▼|PFE27.46-0.27 (-0.96%) ▼|PG146.38+0.25 (+0.17%) ▲|PLTR172.88-0.44 (-0.25%) ▼|PM194.38-0.48 (-0.25%) ▼|QCOM187.77+7.62 (+4.23%) ▲|RTX195.99+0.65 (+0.33%) ▲|SBUX96.78-2.29 (-2.31%) ▼|SCHW107.69+0.38 (+0.35%) ▲|SO86.12-0.88 (-1.01%) ▼|SPG203.93-1.05 (-0.51%) ▼|T26.79+0.28 (+1.04%) ▲|TMO638.90+25.75 (+4.20%) ▲|TMUS180.93-1.97 (-1.08%) ▼|TSLA354.55-4.42 (-1.23%) ▼|TXN263.13-0.30 (-0.11%) ▼|UBER71.44-1.20 (-1.65%) ▼|UNH376.65-6.90 (-1.80%) ▼|UNP284.04-1.04 (-0.36%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.31-0.37 (-0.59%) ▼|V375.55+0.27 (+0.07%) ▲|VZ51.43+0.14 (+0.27%) ▲|WFC89.35+0.64 (+0.72%) ▲|WMT108.06-1.02 (-0.94%) ▼|XOM169.00+3.92 (+2.37%) ▲|AAPL330.15-2.93 (-0.88%) ▼|ABBV261.82+0.05 (+0.02%) ▲|ABT102.05-1.04 (-1.01%) ▼|ACN194.66-0.34 (-0.17%) ▼|ADBE260.05-5.55 (-2.09%) ▼|AMAT420.34-3.87 (-0.91%) ▼|AMD503.64+10.23 (+2.07%) ▲|AMGN375.43-6.07 (-1.59%) ▼|AMT177.75+0.81 (+0.46%) ▲|AMZN248.04-5.50 (-2.17%) ▼|AVGO339.59-5.14 (-1.49%) ▼|AXP324.24-3.54 (-1.08%) ▼|BA209.32-0.96 (-0.45%) ▼|BAC59.57+0.10 (+0.16%) ▲|BKNG171.75-3.60 (-2.05%) ▼|BLK1,058.41-7.19 (-0.67%) ▼|BMY63.75-0.36 (-0.55%) ▼|BNY155.31-2.36 (-1.49%) ▼|BRK-B515.35+0.40 (+0.08%) ▲|C136.06-0.12 (-0.09%) ▼|CAT782.00-2.01 (-0.26%) ▼|CL87.11-0.78 (-0.89%) ▼|CMCSA24.54-0.35 (-1.39%) ▼|COF206.82+0.14 (+0.07%) ▲|COP140.51+3.84 (+2.81%) ▲|COST902.45-16.46 (-1.79%) ▼|CRM255.60-3.83 (-1.48%) ▼|CSCO110.05-0.01 (-0.01%) ▼|CVS94.67-0.88 (-0.92%) ▼|CVX216.81+4.64 (+2.18%) ▲|DE682.14+0.68 (+0.10%) ▲|DHR208.76+5.51 (+2.71%) ▲|DIS106.22-2.38 (-2.19%) ▼|DUK118.22-0.80 (-0.67%) ▼|EMR146.88-1.42 (-0.96%) ▼|FDX309.40-3.17 (-1.01%) ▼|GD359.64+2.83 (+0.79%) ▲|GE308.21-9.35 (-2.94%) ▼|GEV880.60+5.84 (+0.67%) ▲|GILD145.79+0.20 (+0.13%) ▲|GM85.32-1.84 (-2.11%) ▼|GOOG340.28-5.43 (-1.57%) ▼|GOOGL343.77-5.62 (-1.61%) ▼|GS974.89-13.57 (-1.37%) ▼|HD305.45-5.42 (-1.74%) ▼|HON204.74+3.36 (+1.67%) ▲|IBM248.04-1.06 (-0.42%) ▼|INTC97.14-0.05 (-0.05%) ▼|INTU331.51-7.64 (-2.25%) ▼|ISRG377.03-0.91 (-0.24%) ▼|JNJ266.35+0.03 (+0.01%) ▲|JPM353.60+3.47 (+0.99%) ▲|KO88.64-0.18 (-0.20%) ▼|LIN461.69-2.72 (-0.59%) ▼|LLY1,134.06-4.22 (-0.37%) ▼|LMT534.32+4.94 (+0.93%) ▲|LOW195.04-3.14 (-1.58%) ▼|LRCX269.51-3.98 (-1.46%) ▼|MA571.68-2.74 (-0.48%) ▼|MCD253.54-3.96 (-1.54%) ▼|MDLZ62.20-0.19 (-0.30%) ▼|MDT93.74-0.06 (-0.06%) ▼|META668.91+3.31 (+0.50%) ▲|MMM165.08+3.06 (+1.89%) ▲|MO70.11+0.61 (+0.88%) ▲|MRK143.87-0.13 (-0.09%) ▼|MS205.86-0.73 (-0.35%) ▼|MSFT496.00-9.41 (-1.86%) ▼|MU924.38+0.35 (+0.04%) ▲|NEE81.28-0.35 (-0.43%) ▼|NFLX77.96-2.37 (-2.94%) ▼|NKE36.26-0.80 (-2.15%) ▼|NOW142.54+0.19 (+0.13%) ▲|NVDA211.90+0.94 (+0.44%) ▲|ORCL140.19-4.61 (-3.18%) ▼|PEP135.64-0.70 (-0.51%) ▼|PFE27.46-0.27 (-0.96%) ▼|PG146.38+0.25 (+0.17%) ▲|PLTR172.88-0.44 (-0.25%) ▼|PM194.38-0.48 (-0.25%) ▼|QCOM187.77+7.62 (+4.23%) ▲|RTX195.99+0.65 (+0.33%) ▲|SBUX96.78-2.29 (-2.31%) ▼|SCHW107.69+0.38 (+0.35%) ▲|SO86.12-0.88 (-1.01%) ▼|SPG203.93-1.05 (-0.51%) ▼|T26.79+0.28 (+1.04%) ▲|TMO638.90+25.75 (+4.20%) ▲|TMUS180.93-1.97 (-1.08%) ▼|TSLA354.55-4.42 (-1.23%) ▼|TXN263.13-0.30 (-0.11%) ▼|UBER71.44-1.20 (-1.65%) ▼|UNH376.65-6.90 (-1.80%) ▼|UNP284.04-1.04 (-0.36%) ▼|UPS102.58+0.12 (+0.12%) ▲|USB62.31-0.37 (-0.59%) ▼|V375.55+0.27 (+0.07%) ▲|VZ51.43+0.14 (+0.27%) ▲|WFC89.35+0.64 (+0.72%) ▲|WMT108.06-1.02 (-0.94%) ▼|XOM169.00+3.92 (+2.37%) ▲|

22.6 C

New York

Tuesday, September 15, 2026

WellLink Launches National Advisory Board of Healthcare Leaders

Avive and Cambridge Fire Department Join Together for Community CPR/AED Training – Advancing Cambridge’s Vision to Become a 4-Minute Community

/C O R R E C T I O N — TGI Fridays/

Tag: APRIL

ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

NEW YORK, June 26, 2026 (GLOBE NEWSWIRE) --

WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of GeneDx Holdings Corp. (NASDAQ: WGS) between April 16, 2025 and May 4, 2026, inclusive (the “Class Period”), of the important August 3, 2026 lead plaintiff deadline.

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

LIKMEZ® (ATI-1501) commercial momentum building in U.S. market

US$40 million NIAID award supporting VXV-01 advancement through Phase 1

Sportradar Deadline: SRAD Investors with Losses in Excess of $100K Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

NEW YORK, June 26, 2026 /PRNewswire/ -- ...

Hagens Berman Alerts Roblox Corporation (RBLX) Investors to Securities Class Action Amid Surprise Age Verification Impact, $6.7 Billion Market Cap Wipe Out

Investors who lost money in RBLX after its stock plunged due to allegedly misleading financial statements are urged to contact Hagens Berman.

BLUENERGIES PROVIDES DETAILS OF INVESTOR RELATIONS ENGAGEMENTS

TSXV: BLU | OTCQX: BLUGFVANCOUVER, BC, June 26, 2026 /CNW/ - BluEnergies Ltd. (TSXV: BLU) ("BLU" or the "Company") further to its news releases...

Premium Income Corporation Announces Semi-Annual Results

TORONTO, June 26, 2026 (GLOBE NEWSWIRE) -- (TSX: PIC.A; PIC.PR.A) Premium Income Corporation (the “Fund”) announces results of operations for the six months ended April 30, 2026. Increase in net assets attributable to holders of Class A shares amounted to $69.8 million or $3.91 per Class A share. Net assets attributable to holders of Class A shares as at April 30, 2026 were $229.4 million or $12.39 per Class A share ($11.26 per Class A share after giving effect to the May 2026 Share Split). Cash distributions of $0.64 per Preferred share and $0.52 per Class A share were paid during the period.

Bombardier Completes Redemption of All Outstanding 7.35% Debentures due 2026

MONTREAL, June 26, 2026 (GLOBE NEWSWIRE) -- Bombardier Inc. (“Bombardier”) today announced that it has redeemed all outstanding C$150 million aggregate principal amount of its 7.35% Debentures due 2026 (the “2026 Debentures”), as previously announced on April 30, 2026.

Minister Anandasangaree highlights launch of National Food Security Strategy

SCARBOROUGH, ON, June 26, 2026 /CNW/ - The Government of Canada is focused on building a stronger economy and making life more affordable for...

Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

BEERSE, BELGIUM, June 26, 2026 (GLOBE NEWSWIRE) -- Johnson & Johnson today announced new data across 12 abstracts at the European Academy of Neurology (EAN) 2026 Congress that offer additional insight into the use of IMAAVY^®▼(nipocalimab) throughout clinically relevant points in the generalised myasthenia gravis (gMG) treatment journey. The analyses include adults with anti-AChR^a or anti-MuSK^b antibody-positive gMG who were early in their disease course or had lower baseline symptom burden – providing insight into the potential importance of addressing pathogenic immunoglobulin G (IgG) early in disease progression where use of advanced therapies may be less common.¹^,² Additional research to be shared include outcomes shortly after common infections, which are a known cause of disease exacerbations in gMG, and plans to address evidence gaps in the use of nipocalimab during pregnancy.³^,⁴

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

New analyses from the Phase 3 Vivacity-MG3 study support the impact of IMAAVY in anti-AChR+a, anti-MuSK+b adult patients with generalized myasthenia gravis (gMG) including...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Company Name

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

This field is for validation purposes and should be left unchanged.

HomeTagsAPRIL

WellLink Launches National Advisory Board of Healthcare Leaders

Avive and Cambridge Fire Department Join Together for Community CPR/AED Training – Advancing Cambridge’s Vision to Become a 4-Minute Community

/C O R R E C T I O N — TGI Fridays/

Tag: APRIL

ROSEN, A LEADING NATIONAL FIRM, Encourages GeneDx Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – WGS

Appili Therapeutics Reports Fiscal Year 2026 Financial and Operational Results

Sportradar Deadline: SRAD Investors with Losses in Excess of $100K Have Opportunity to Lead Sportradar Group AG Securities Fraud Lawsuit

Hagens Berman Alerts Roblox Corporation (RBLX) Investors to Securities Class Action Amid Surprise Age Verification Impact, $6.7 Billion Market Cap Wipe Out

BLUENERGIES PROVIDES DETAILS OF INVESTOR RELATIONS ENGAGEMENTS

Premium Income Corporation Announces Semi-Annual Results

Bombardier Completes Redemption of All Outstanding 7.35% Debentures due 2026

Minister Anandasangaree highlights launch of National Food Security Strategy

Johnson & Johnson presents new IMAAVY®▼ (nipocalimab) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalised myasthenia gravis

Johnson & Johnson presents new IMAAVY® (nipocalimab-aahu) data at European Academy of Neurology (EAN) 2026 Congress reinforcing sustained disease control in generalized myasthenia gravis

Board decision to file for bankruptcy

T7X Announces Infrastructure Platform for Compliant On-Chain Securities Issuance and Transfer Agent Services

Seaspan Releases 2025 Sustainability Report, Highlighting Continued Progress on Decarbonization, Safety and Governance

Nuvation Bio Announces Pricing of Upsized Offering of $250.0 million of Convertible Senior Notes

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us